Journal of Clinical Case Reports

ISSN: 2165-7920

Open Access

Metabolic-Associated Fatty Liver Disease - A Silent or an Aggressive Killer? A Case Report


Oana-Bogdana Bărboi, Vasile-Liviu Drug*, Alina Pleșa, Diana-Elena Iov, Radu-Alexandru Vulpoi, Ludmila Știrbu, Mariana Floria and Irina Ciortescu

The rising incidence of hepatocellular carcinoma (HCC) in non-cirrhotic patients in recent years implies the presence of other factors that could contribute to liver carcinogenesis. Metabolic-associated fatty liver disease (MAFLD) can progress to HCC, which poses a significant burden on the healthcare systems worldwide and has a high mortality rate. An aggressive non-invasive surveillance strategy is necessary in order to detect liver cancer in non-cirrhotic patients, especially in those with risk factors such as diabetes, obesity or older age. An acute clinical presentation is possible through complications, such as the development of hemoperitoneum due to the non-traumatic HCC rupture.


Share this article

Google Scholar citation report
Citations: 1215

Journal of Clinical Case Reports received 1215 citations as per Google Scholar report

Journal of Clinical Case Reports peer review process verified at publons

Indexed In

arrow_upward arrow_upward